[1] Danan G, Bénichou C. Causality assessment of adverse reactions to drugs—I. A novel method based on the conclusions of international consensus meetings: Application to drug-induced liver injuries. J Clin Epidemiol, 1993, 46(11): 1323-1330.
[2] Danan G, Teschke R. RUCAM in drug and herb induced liver injury: the update. Int J Mol Sci,2015,17(1):14.
[3] Rockey DC, Seeff LB, Rochon J, et al. Causality Assessment in Drug-Induced Liver Injury Using a Structured Expert Opinion Process: Comparison to the Roussel-Uclaf Causality Assessment Method. Hepatology, 2010, 51(6):2117-2126.
[4] Maria and Victorino (M & V) System of Causality Assessment in Drug Induced Liver Injury. In: LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-2019 May 4.
[5] Das S, Behera SK, Xavier AS, et al. Agreement Among Different Scales for Causality Assessment in Drug-Induced Liver Injury. Clin Drug Investig, 2018, 38(3):211-218.
[6] Danan G, Teschke R. Drug-Induced Liver Injury: Why is the Roussel Uclaf Causality Assessment Method?(RUCAM) Still Used 25 Years After Its Launch? Drug Saf,2018,41(8):735-743.
[7] Bénichou C. Criteria of drug-induced liver disorders. Report of an international consensus meeting. J Hepatol,1990, 11(2):272-276.
[8] 于乐成, 陈成伟. 药物性肝损伤. 肝脏, 2008, 13(3): 238-243.
[9] 于乐成, 陈成伟. 新版RUCAM:药物和草药诱导性肝损伤的重要评估工具. 肝脏, 2016, 21(6): 493-500.
[10] 于乐成,茅益民,陈成伟. 对新版RUCAM量表的评价和几点商榷意见. 肝脏, 2016, 21(6): 432-433.
[11] Hayashi PH, Isabel Lucena M, Fontana RJ, et al. A revised electronic version of RUCAM for the diagnosis of DILI. Hepatology, 2022, 76(1):18-31.
[12] Lewis JH. Digitizing DILI: Who can? RUCAM? RECAM? Hepatology, 2022, 76(1): 3-5. |
